G. Raghu
- The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumoniasBy G. Raghu, A. G. Nicholson and D. LynchG. RaghuA. G. Nicholson
- The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosisBy T. S. Hallstrand, L. J. Boitano, W. C. Johnson, C. A. Spada, J. G. Hayes and G. RaghuT. S. HallstrandL. J. BoitanoW. C. JohnsonC. A. SpadaJ. G. Hayes
- High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosisBy G. Raghu, T. D. Freudenberger, S. Yang, J. R. Curtis, C. Spada, J. Hayes, J. K. Sillery, C. E. Pope and C. A. PellegriniG. RaghuT. D. FreudenbergerS. YangJ. R. CurtisC. SpadaJ. HayesJ. K. SilleryC. E. Pope II
- Clinical trials in idiopathic pulmonary fibrosis: a word of caution concerning choice of outcome measuresBy W. C. Johnson and G. Raghu
- From the authorsBy G. Raghu and W. C. Johnson
- From the authorsBy G. Raghu
- Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)By G. Raghu, T. E. King, J. Behr, K. K. Brown, R. M. du Bois, I. Leconte, S. Roux and J. SwigrisG. RaghuT. E. King JrJ. BehrK. K. BrownR. M. du BoisI. LeconteS. Roux
- Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biologyBy C. Vancheri, M. Failla, N. Crimi and G. RaghuC. VancheriM. FaillaN. Crimi
- Pirfenidone in idiopathic pulmonary fibrosisBy H. Taniguchi, M. Ebina, Y. Kondoh, T. Ogura, A. Azuma, M. Suga, Y. Taguchi, H. Takahashi, K. Nakata, A. Sato, M. Takeuchi, G. Raghu, S. Kudoh, T. Nukiwa and the Pirfenidone Clinical Study Group in JapanH. TaniguchiM. EbinaY. KondohT. OguraA. AzumaM. SugaY. TaguchiH. TakahashiK. NakataA. SatoM. TakeuchiG. RaghuS. Kudoh
- Silent gastro-oesophageal reflux and microaspiration in IPF: mounting evidence for anti-reflux therapy?By G. Raghu and K.C. Meyer
- Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?By K.C. Meyer and G. Raghu
- Impact of bosentan on health-related quality of life and dyspnoea in idiopathic pulmonary fibrosis: the BUILD-1 trialBy G. Raghu, T.E. King Jr, J. Behr, K.K. Brown, R.M. du Bois, I. Leconte, S. Roux and J. SwigrisArticle | Published in 2009 in European Respiratory JournalG. RaghuT.E. King JrJ. BehrK.K. BrownR.M. du BoisI. LeconteS. Roux
- Pirfenidone in idiopathic pulmonary fibrosisBy H. Taniguchi, M. Ebina, Y. Kondoh, T. Ogura, A. Azuma, M. Suga, Y. Taguchi, H. Takahashi, K. Nakata, A. Sato, M. Takeuchi, G. Raghu, S. Kudoh and T. NukiwaArticle | Published in 2009 in European Respiratory JournalH. TaniguchiM. EbinaY. KondohT. OguraA. AzumaM. SugaY. TaguchiH. TakahashiK. NakataA. SatoM. TakeuchiG. RaghuS. Kudoh
- Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?By K.C. Meyer and G. RaghuArticle | Published in 2011 in European Respiratory Journal
- Interstitial Lung DiseasesEdited by R.M. du Bois and L. RicheldiBook | Published in 2009DOI: 10.1183/1025448x.ERM4609ISBN (electronic): 978-1-904097-97-6
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.